January 13, 2021
The BLB&G trial team of Mark Lebovitch, Gregory V. Varallo, and Thomas James challenged a novel anti-shareholder corporate governance provision in Delaware Chancery Court. This closely-watched trial marks the first full-blown challenge to the most recent—and harmful—poison pill developments. Press coverage of the case is highlighted in the links below, and can also be accessed in the PDFs. More information about the case can be accessed using the Related Case link on the left-hand sidebar.
External Links (links will open in a new window):
The Deal "Williams Pill Breaches Director Fiduciary Duty: Wolosky"
Law360 "Chancery Opens Trial on Williams' 'Nuclear' Takeover Defense"
Law360 "Williams Expert Says Poison Pill No Threat To Shareholders"